Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. (603707.SS) revealed a profit for first quarter of RMB89.01 million
The company's earnings totaled RMB89.01 million, or RMB0.05 per share. This compares with RMB84.71 million, or RMB0.05 per share, last year.
The company's revenue for the period rose 4.9% to RMB928.66 million from RMB885.21 million last year.
Nanjing King-Friend Biochemical Pharmaceutical Co.,Ltd. earnings at a glance (GAAP) :
-Earnings: RMB89.01 Mln. vs. RMB84.71 Mln. last year.-EPS: RMB0.05 vs. RMB0.05 last year.-Revenue: RMB928.66 Mln vs. RMB885.21 Mln last year.
For comments and feedback contact: editorial@rttnews.com
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.